1.65 USD
↘ 0.03 (1.79%)LIVE (AS OF 09:37 AM EDT)
MetaVia Inc. Common Stock
MTVANASDAQ • USD
Market: OPEN
MetaVia Inc. Common Stock (MTVA) trades at $1.65 per share. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest MTVA is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Aug 26, 2026.
Open?$1.64
High?$1.67
Low?$1.64
Prev. Close?$1.68
Volume?3.1K
Avg. Volume?89.9K
VWAP?$1.65
Rel. Volume?0.03x
Bid / Ask
Bid?$1.38 × 100
Ask?$1.93 × 100
Spread?$0.55
Midpoint?$1.65
Valuation & Ratios
Market Cap?11.1M
Shares Out?5.2M
Float?3.4M
Float %?65.2%
P/E Ratio?N/A
P/B Ratio?1.62
EPS?-$2.19
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. Vanoglipel (DA-1241) is a novel GPR119 (GPR119) agonist with development optionality as a standalone or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). Agonism of GPR119 in the gut promotes the release of key gut peptides, glucagon-like peptide-1 (GLP-1), glucagon-dependent insulinotropic polypeptide receptor (GIP), and peptide YY.
Employees
8
Market Cap
11.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2016-08-04
Address
545 CONCORD AVENUE
CAMBRIDGE, MA 02138
Phone: (857) 702-9600
CAMBRIDGE, MA 02138
Phone: (857) 702-9600
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?45
Piotroski F-Score?0/9Weak
Altman Z-Score?-18.74Distress
Confidence?48%Low
Short InterestElevated
Short % of Float?6.28%Elevated
Short Interest?211.3K
Days to Cover?2.5
Free Float3.4M
Avg Daily Volume84.1K
Settlement Date2026-08-14
Financial Health
Current Ratio?2.06Strong
Quick Ratio?2.06Strong
Cash Ratio?1.99Strong
Debt/Equity?0.42Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.62CHEAP▾
Peers100
S&P84
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-211.8%WEAK▾
S&P3
ROA?-108.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-15835000
Enterprise Value?$1.3M
Fundamentals ratios updated end of day